The historic term 'histiocytosis' meaning 'tissue cell'is used as a unifying concept for
diseases characterized by pathogenic myeloid cells that share histological features with …

Langerhans cell histiocytosis (LCH) is caused by clonal expansion of myeloid precursors
that differentiate into CD1a+/CD207+ cells in lesions that leads to a spectrum of organ …

Langerhans cell histiocytosis (LCH) can affect children and adults with a wide variety of
clinical manifestations, including unifocal, single-system multifocal, single-system pulmonary …

Histiocytoses constitute a heterogeneous group of rare disorders, characterised by
infiltration of almost any organ by myeloid cells with diverse macrophage or dendritic cell …

Histiocytic neoplasms are rare hematologic disorders accounting for less than 1% of cancers
of the soft tissue and lymph nodes. Clinical presentation and prognosis of these disorders …

Advances in the treatment of Langerhans cell histiocytosis (LCH) have resulted in a growing
survivor population. There is a lack of data on long-term outcomes among adults with LCH …

Pulmonary Langerhans cell (LC) histiocytosis (PLCH) has unknown cause and is a rare
neoplastic disorder characterized by the infiltration of lungs and various organs by bone …

Histiocytic disorders are a spectrum of rare diseases characterised by the accumulation of
macrophage‐, dendritic cell‐, or monocyte‐differentiated cells in various tissues and organs …

Background Langerhans cell histiocytosis (LCH) is a rare disorder of histiocyte proliferation.
Previous case studies suggest a higher prevalence of hematologic and solid malignancies …

Histiocytic disorders are rare diseases defined by the clonal accumulation of a macrophage
or dendritic cell origin. These disorders include Langerhans cell histiocytosis, Erdheim …